Using Decision Analysis to Support the Design of Clinical Trials Within a Program

Richard Nixon () and Blair Ireland ()
Additional contact information
Richard Nixon: Novartis Pharma AG
Blair Ireland: One Health Plaza

Chapter Chapter 7 in Optimization of Pharmaceutical R&D Programs and Portfolios, 2015, pp 105-122 from Springer

Abstract: Abstract Drug development involves complex, high-value decisions with lasting consequences. These decisions are made in the context of uncertainty, with information of many different types and from many different sources. A project team making a decision regarding the development of a drug needs to structure and synthesize this information in this context and come to a consensus on the best course of action.

Keywords: Decision Analysis; Drug development; Clinical trial simulation; Clinical trial design; Clinical program simulation; Clinical development plan; Expected net present value (search for similar items in EconPapers)
Date: 2015
References: Add references at CitEc
Citations: View citations in EconPapers (1)

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-319-09075-7_7

Ordering information: This item can be ordered from
http://www.springer.com/9783319090757

DOI: 10.1007/978-3-319-09075-7_7

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().